Modeling and Simulation Archives

Publication

Critical Roles for Modeling and Simulation and Real-World Evidence to Inform Challenges in Clinical Trial Diversity Planning

Due to the highly controlled settings of clinical trials, enrolled subjects may not be fully…

Danielle Pillsbury2025年6月19日

Webinar

From Data to Decisions: Real-World Impact of Model-Based Meta-Analysis (MBMA) with GSK and Certara

Certara2025年6月18日

Blog

Redefining Regulatory Strategy with MIDD: Insights from the Draft ICH M15 Guidance

With the release of the draft ICH M15 guidance, MIDD is no longer optional -…

Certara2025年6月11日

On-Demand Webinar

Evolving Regulatory Landscape for Model Informed Drug Development (MIDD): Impact of the Draft ICH M15 Guidance

SVP, PBPK Consultancy Services, Certara SVP, Quantitative Science Services, Certara Sr. Director, Clinical Pharmacology, Certara…

Certara2025年5月23日

Blog

CERTAINTY 2025: The power of Model-Informed Drug Development

We cover the key takeaways from CERTAINTY 2025, including the power of Model-Informed Drug Development…

Certara2025年5月16日

Webinar

Explore First: How a Stepwise Approach to QTc Studies Reduces Time, Cost, and Regulatory Risk

Certara2025年5月5日

Fact Sheet

Non-Animal Navigator™: 動物実験の削減、改善、代替を実現する戦略とAIを活用したシミュレーション

サターラのNon-Animal Navigator™ソリューションは、企業が最適なNAM戦略を選択し最適化できるよう支援します。

Certara2025年4月30日

Announcement

サターラ、第 2 回「Certainty U.S.」イベントの開催を発表

Certara’s premier client conference explores how in-silico methods and biosimulation at scale derisk every stage…

Certara2025年4月22日

Blog

In case you missed it: CHI + Certara Webinar on Artificial Intelligence (AI) -Powered Model-Informed Drug Development (MIDD)

2025年4月18日 What’s next for drug development? Recapping our MIDD in the age of…

Certara2025年4月18日

Press Release

Certara Launches Non-Animal Navigator™ Solution to Help Drug Developers Reduce Reliance on Animal Testing

New offering provides strategic guidance and AI-enabled biosimulation to navigate FDA’s Roadmap to Reducing Animal…

Certara2025年4月14日

Powered by Translations.com GlobalLink Web Software

モデリング＆シミュレーション

Critical Roles for Modeling and Simulation and Real-World Evidence to Inform Challenges in Clinical Trial Diversity Planning

From Data to Decisions: Real-World Impact of Model-Based Meta-Analysis (MBMA) with GSK and Certara

Redefining Regulatory Strategy with MIDD: Insights from the Draft ICH M15 Guidance

Evolving Regulatory Landscape for Model Informed Drug Development (MIDD): Impact of the Draft ICH M15 Guidance

CERTAINTY 2025: The power of Model-Informed Drug Development

Explore First: How a Stepwise Approach to QTc Studies Reduces Time, Cost, and Regulatory Risk

Non-Animal Navigator™: 動物実験の削減、改善、代替を実現する戦略とAIを活用したシミュレーション

サターラ、第 2 回「Certainty U.S.」イベントの開催を発表

In case you missed it: CHI + Certara Webinar on Artificial Intelligence (AI) -Powered Model-Informed Drug Development (MIDD)

Certara Launches Non-Animal Navigator™ Solution to Help Drug Developers Reduce Reliance on Animal Testing

メルマガ登録

クイックアクセス

ソリューション

お問合せ